Matthew T. Hueman - Concepedia

Author

Matthew T. Hueman

Uniformed Services University of the Health Sciences

Also Known As

M. Hueman, M. T. Hueman, M.T. Hueman, MATTHEW HUEMAN, Matthew Hueman, Matthew T Hueman, Matthew T. Hueman

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Uniformed Services University of the Health Sciences Walter Reed National Military Medical Center Walter Reed Army Institute of Research George Washington University Windber Research Institute

About

Matthew T. Hueman is an author at Uniformed Services University of the Health Sciences specializing in medicine, immunotherapy, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	691
2	Biostatistics	3	3	66
3	Engineering	2	2	50
4	Data Science	2	2	50
5	Public Health	1	1	12

Matthew T. Hueman

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Comparison of Benefits on Myocardial Performance of Cellular Cardiomyoplasty with Skeletal Myoblasts and Fibroblasts Kelley A. Hutcheson, B. Zane Atkins, Matthew T. Hueman, Cell Transplantation	2000	187
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients Jennifer M. Gurney, Matthew T. Hueman, Michael Woll, Journal of Clinical Oncology Breast OncologyImmunologyImmune RegulationPathologyImmunodominance	2005	183
Combined Clinical Trial Results of a HER2/<i>neu</i>(E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 George E. Peoples, Jarrod P. Holmes, Matthew T. Hueman, Clinical Cancer Research	2008	179
Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/<i>neu</i>Peptide (AE37) Vaccine Jarrod P. Holmes, Linda C. Benavides, Jeremy D. Gates, Journal of Clinical Oncology	2008	136
Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium B. Zane Atkins, Matthew T. Hueman, Jennifer M. Meuchel, The Journal of Heart and Lung Transplantation Regenerative MedicineCardiac MuscleHeart FailureTransplantationCardiovascular Translational Research	1999	117
The Impact of HER2/<i>neu</i>Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 Linda C. Benavides, Jeremy D. Gates, Mark G. Carmichael, Clinical Cancer Research	2009	116
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technology Zia A. Dehqanzada, Catherine E. Storrer, Matthew T. Hueman, Oncology Reports	2007	82
Cellular Cardiomyoplasty Improves Diastolic Properties of Injured Heart B. Zane Atkins, Matthew T. Hueman, Jennifer M. Meuchel, Journal of Surgical Research Cardiac MuscleCardiomyopathyHeart FailureStructural Heart DiseaseCardiovascular Disease	1999	82
Phase I Clinical Trial of a HER-2/<i>neu</i> Peptide (E75) Vaccine for the Prevention of Prostate-Specific Antigen Recurrence in High-Risk Prostate Cancer Patients Matthew T. Hueman, Zia A. Dehqanzada, Thomas E. Novak, Clinical Cancer Research	2005	53
Optimal dose and schedule of an HER‐2/<i>neu</i> (E75) peptide vaccine to prevent breast cancer recurrence Jarrod P. Holmes, Jeremy D. Gates, Linda C. Benavides, Cancer	2008	50

Page 1